ClinVar Miner

Submissions for variant NM_206933.3(USH2A):c.9871G>A (p.Gly3291Ser) (rs138543813)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000665320 SCV000789420 uncertain significance Usher syndrome, type 2A; Retinitis pigmentosa 39 2017-01-31 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000825851 SCV000967335 likely benign not specified 2018-04-03 criteria provided, single submitter clinical testing The p.Gly3291Ser variant has been previously reported in one individual with Ush er syndrome; however the variant reported on the other allele (p.Tyr1992Cys) is classified as benign based on its frequency (Krawitz 2014). The p.Gly3291Ser var iant has been identified in 0.05% (59/126516) European chromosomes by the Genome Aggregation Database (gnomAD,; dbSNP rs1385438 13). Although this variant has been seen in the general population, its frequen cy is not high enough to rule out a pathogenic role. Computational prediction to ols and conservation analyses suggest that this variant may not impact the prote in, and at least one mammal (shrew) has a Serine at this residue as do other low er species (birds, reptiles, fish). In summary, the clinical significance of the p.Gly3291Ser variant is likely benign. ACMG/AMP Criteria applied: BP4_Strong.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.